Nicotinic Acid Under Review by EMA, Following HPS2-THRIVENicotinic Acid Under Review by EMA, Following HPS2-THRIVE

Agencies worldwide suspended the marketing of niacin/laropiprant products in January; the new announcement from the European regulator is extending the review to products containing only nicotinic acid (or related substances). Heartwire

Source: Medscape Today Headlines - March 8, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news